Bausch Health Posts Strong Q3, Accelerating Its Deleveraging Journey

Pharma company Bausch Health Companies Inc. (BHC) delivered an impressive third quarter, beating expectations and making clear strides on its debt‑reduction path. Revenue rose significantly year‑over‑year, thanks to growth in key segments and improved operational efficiency. Management highlighted that freeing up cash flow and reducing leverage are top priorities, and the Q3 results suggest they’re gaining traction. Meanwhile, BHC reaffirmed its full‑year guidance and signalled confidence in further deleveraging, with cost controls and portfolio optimization playing key roles. All told, investors got more than just a quarterly beat — they got proof that Bausch is serious about cleaning up its balance sheet. #BauschHealth #PharmaEarnings #Deleveraging #HealthcareStocks #SlimScan #GrowthStocks #CANSLIM